Viewing Study NCT02254967


Ignite Creation Date: 2025-12-25 @ 12:36 AM
Ignite Modification Date: 2026-01-18 @ 5:11 PM
Study NCT ID: NCT02254967
Status: COMPLETED
Last Update Posted: 2024-10-31
First Post: 2014-09-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase IIIB/IV Study to Compare the Efficacy of Vancomycin Therapy to Extended Duration of Fidaxomicin Therapy in the Clinical Cure of Clostridium Difficile Infection (CDI) in an Older Population
Sponsor: Astellas Pharma Europe Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2014-11-06
Start Date Type: ACTUAL
Primary Completion Date: 2016-03-27
Primary Completion Date Type: ACTUAL
Completion Date: 2016-05-05
Completion Date Type: ACTUAL
First Submit Date: 2014-09-25
First Submit QC Date: None
Study First Post Date: 2014-10-02
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-10-29
Last Update Post Date: 2024-10-31
Last Update Post Date Type: ACTUAL